Exagen Diagnostics Inc.
This article was originally published in Start Up
Executive Summary
Exagen Diagnostics Inc. is using a cutting-edge computational platform developed for the auto parts industry to identify biomarkers and proprietary technologies to converting these markers to familiar fluorescent in situ hybridization (FISH) formats. The two-year-old company is developing these into clinical molecular diagnostics.